Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) EBT Margin: 2020-2025

Historic EBT Margin for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -13.13%.

  • Journey Medical's EBT Margin rose 321.00% to -13.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -14.38%, marking a year-over-year increase of 1714.00%. This contributed to the annual value of -26.03% for FY2024, which is 2144.00% down from last year.
  • According to the latest figures from Q3 2025, Journey Medical's EBT Margin is -13.13%, which was up 47.25% from -24.89% recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's EBT Margin peaked at 48.88% during Q3 2023, and registered a low of -99.99% during Q2 2021.
  • In the last 3 years, Journey Medical's EBT Margin had a median value of -22.63% in 2024 and averaged -24.78%.
  • Per our database at Business Quant, Journey Medical's EBT Margin plummeted by 10,151bps in 2021 and then spiked by 11,137bps in 2023.
  • Journey Medical's EBT Margin (Quarterly) stood at -76.59% in 2021, then surged by 1,002bps to -66.57% in 2022, then surged by 5,335bps to -13.22% in 2023, then soared by 2,484bps to 11.62% in 2024, then spiked by 321bps to -13.13% in 2025.
  • Its EBT Margin was -13.13% in Q3 2025, compared to -24.89% in Q2 2025 and -31.00% in Q1 2025.